|
1
|
Peltier J, O'Neill A and Schaffer DV:
PI3K/Akt and CREB regulate adult neural hippocampal progenitor
proliferation and differentiation. Dev Neurobiol. 67:1348–1361.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang G, Wang F, Ding W, Wang J, Jing R, Li
H, Wang X, Wang Y, Ju S and Wang H: APRIL induces tumorigenesis and
metastasis of colorectal cancer cells via activation of the
PI3K/Akt pathway. PLoS One. 8:e552982013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Reilly KE, Rojo F, She QB, Solit D,
Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, et al:
mTOR inhibition induces upstream receptor tyrosine kinase signaling
and activates Akt. Cancer Res. 66:1500–1508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tabernero J, Rojo F, Calvo E, Burris H,
Judson I, Hazell K, Martinelli E, Ramon y Cajal S, Jones S, Vidal
L, et al: Dose- and schedule-dependent inhibition of the mammalian
target of rapamycin pathway with everolimus: A phase I tumor
pharmacodynamic study in patients with advanced solid tumors. J
Clin Oncol. 26:1603–1610. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu TJ, Koul D, LaFortune T, Tiao N, Shen
RJ, Maira SM, Garcia-Echevrria C and Yung WK: NVP-BEZ235, a novel
dual phosphatidylinositol 3-kinase/mammalian target of rapamycin
inhibitor, elicits multifaceted antitumor activities in human
gliomas. Mol Cancer Ther. 8:2204–2210. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji Y, Di W, Yang Q, Lu Z, Cai W and Wu J:
Inhibition of autophagy increases proliferation inhibition and
apoptosis induced by the PI3K/mTOR inhibitor NVP-BEZ235 in breast
bancer bells. Clin Lab. 61:1043–1051. 2015.
|
|
7
|
Li C, Xin P, Xiao H, Zheng Y, Huang Y and
Zhu X: The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits
proliferation and induces apoptosis of Burkitt lymphoma cells.
Cancer Cell Int. 15:652015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sacco A, Roccaro A and Ghobrial IM: Role
of dual PI3/Akt and mTOR inhibition in Waldenstrom's
Macroglobulinemia. Oncotarget. 1:578–582. 2010. View Article : Google Scholar
|
|
9
|
Dubrovska A, Elliott J, Salamone RJ, Kim
S, Aimone LJ, Walker JR, Watson J, Sauveur-Michel M,
Garcia-Echeverria C, Cho CY, et al: Combination therapy targeting
both tumor-initiating and differentiated cell populations in
prostate carcinoma. Clin Cancer Res. 16:5692–5702. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang WJ, Long LM, Yang N, Zhang QQ, Ji WJ,
Zhao JH, Qin ZH, Wang Z, Chen G and Liang ZQ: NVP-BEZ235, a novel
dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human
glioma stem cells in vitro. Acta Pharmacol Sin. 34:681–690. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hernlund E, Olofsson MH, Fayad W, Fryknäs
M, Lesiak-Mieczkowska K, Zhang X, Brnjic S, Schmidt V, D'Arcy P,
Sjöblom T, et al: The phosphoinositide 3-kinase/mammalian target of
rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth
of tumour cells after cytotoxic therapy. Eur J Cancer. 48:396–406.
2012. View Article : Google Scholar
|
|
12
|
Li CH, Cai L, Chen XS, Meng QW and Sui GJ:
DDP-sensitivity-related genes in 10 lung cancer cell lines.
Zhonghua Zhong Liu Za Zhi. 30:418–421. 2008.(In Chinese).
PubMed/NCBI
|
|
13
|
Shen Y, Ren M, Shi Y, Zhang Y and Cai Y:
Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer
cell line to cisplatin chemotherapy in vitro. Exp Ther Med.
2:1171–1176. 2011.
|
|
14
|
Weng Y, Wang Y, Shi Y, Zhou W, Wang H and
Wang C: TLR9 expression and its role in chemosensitivity to DDP in
human cervical cancer cells in vitro. J Huazhong Univ Sci Technolog
Med Sci. 31:550–554. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cakir E, Yilmaz A, Demirag F, Oguztuzun S,
Sahin S, Yazici UE and Aydin M: Prognostic significance of
micropapillary pattern in lung adenocarcinoma and expression of
apoptosis-related markers: Caspase-3, bcl-2, and p53. APMIS.
119:574–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cherra SJ III, Kulich SM, Uechi G,
Balasubramani M, Mountzouris J, Day BW and Chu CT: Regulation of
the autophagy protein LC3 by phosphorylation. J Cell Biol.
190:533–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pópulo H, Lopes JM and Soares P: The mTOR
signalling pathway in human cancer. Int J Mol Sci. 13:1886–1918.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimura T, Sasatani M, Kamiya K, Kawai H,
Inaba Y and Kunugita N: Mitochondrial reactive oxygen species
perturb AKT/cyclin D1 cell cycle signaling via oxidative
inactivation of PP2A in lowdose irradiated human fibroblasts.
Oncotarget. 7:3559–3570. 2015.PubMed/NCBI
|
|
21
|
Jin ZJ: About the evaluation of drug
combination. Acta Pharmacol Sin. 25:146–147. 2004.PubMed/NCBI
|
|
22
|
Rafalski VA and Brunet A: Energy
metabolism in adult neural stem cell fate. Prog Neurobiol.
93:182–203. 2011. View Article : Google Scholar
|
|
23
|
Wyatt LA, Filbin MT and Keirstead HS: PTEN
inhibition enhances neurite outgrowth in human embryonic stem
cell-derived neuronal progenitor cells. J Comp Neurol.
522:2741–2755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ojeda L, Gao J, Hooten KG, Wang E,
Thonhoff JR, Dunn TJ, Gao T and Wu P: Critical role of
PI3K/Akt/GSK3β in moto-neuron specification from human neural stem
cells in response to FGF2 and EGF. PLoS One. 6:e234142011.
View Article : Google Scholar
|
|
25
|
Sui L, Wang J and Li BM: Role of the
phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin
signaling pathway in long-term potentiation and trace fear
conditioning memory in rat medial prefrontal cortex. Learn Mem.
15:762–776. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dubrovska A, Kim S, Salamone RJ, Walker
JR, Maira SM, García-Echeverría C, Schultz PG and Reddy VA: The
role of PTEN/Akt/PI3K signaling in the maintenance and viability of
prostate cancer stem-like cell populations. Proc Natl Acad Sci USA.
106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kanai R, Wakimoto H, Martuza RL and Rabkin
SD: A novel oncolytic herpes simplex virus that synergizes with
phosphoinositide 3-kinase/Akt pathway inhibitors to target
glioblastoma stem cells. Clin Cancer Res. 17:3686–3696. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen J, Shao R, Li F, Monteiro M, Liu JP,
Xu ZP and Gu W: PI3K/Akt/mTOR pathway dual inhibitor BEZ235
suppresses the stemness of colon cancer stem cells. Clin Exp
Pharmacol Physiol. 42:1317–1326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Apps MG, Choi EH and Wheate NJ: The
state-of-play and future of platinum drugs. Endocr Relat Cancer.
22:R219–R233. 2015.PubMed/NCBI
|
|
30
|
Horie R, Nakamura O, Yamagami Y, Mori M,
Nishimura H, Fukuoka N and Yamamoto T: Apoptosis and antitumor
effects induced by the combination of an mTOR inhibitor and an
autophagy inhibitor in human osteosarcoma MG63 cells. Int J Oncol.
48:37–44. 2016.
|
|
31
|
Wani ZA, Guru SK, Rao AV, Sharma S,
Mahajan G, Behl A, Kumar A, Sharma PR, Kamal A, Bhushan S, et al: A
novel quinazolinone chalcone derivative induces mitochondrial
dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in
human colon cancer HCT-116 cells. Food Chem Toxicol. 87:1–11. 2016.
View Article : Google Scholar
|
|
32
|
Sui H, Shi C, Yan Z and Li H: Combination
of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor
xenografts due to increased autophagy. Drug Des Devel Ther.
9:3183–3190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin SJ, Leng ZG, Guo YH, Cai L, Cai Y, Li
N, Shang HB, Le WD, Zhao WG and Wu ZB: Suppression of mTOR pathway
and induction of autophagy-dependent cell death by cabergoline.
Oncotarget. 6:39329–39341. 2015.PubMed/NCBI
|
|
34
|
Zou M, Hu C, You Q, Zhang A, Wang X and
Guo Q: Oroxylin A induces autophagy in human malignant glioma cells
via the mTOR-STAT3-Notch signaling pathway. Mol Carcinog.
54:1363–1375. 2015. View
Article : Google Scholar
|
|
35
|
Chen ZH, Lam HC, Jin Y, Kim HP, Cao J, Lee
SJ, Ifedigbo E, Parameswaran H, Ryter SW and Choi AM: Autophagy
protein microtubule-associated protein 1 light chain-3B (LC3B)
activates extrinsic apoptosis during cigarette smoke-induced
emphysema. Proc Natl Acad Sci USA. 107:18880–18885. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meyer G, Czompa A, Reboul C, Csepanyi E,
Czegledi A, Bak I, Balla G, Balla J, Tosaki A and Lekli I: The
cellular autophagy markers Beclin-1 and LC3B-II are increased
during reperfusion in fibrillated mouse hearts. Curr Pharm Des.
19:6912–6918. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pruefer FG, Lizarraga F, Maldonado V and
Melendez-Zajgla J: Participation of Omi Htra2 serine-protease
activity in the apoptosis induced by cisplatin on SW480 colon
cancer cells. J Chemother. 20:348–354. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cohen SM, Mikata Y, He Q and Lippard SJ:
HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG)
cross-links in purine-rich sequence contexts. Biochemistry.
39:11771–11776. 2000. View Article : Google Scholar : PubMed/NCBI
|
